Get started
Author

Sofia Côrte‐Real

Observed names: Sofia Corte-Real, Sofia Corte‐Real, Sofia Côrte-Real, Sofia V Corte Real
Observed institutions: Scripps Research Institute, University of Lisbon, University of Pittsburgh, UPMC Hillman Cancer Center, TechnoPhage (Portugal), Instituto de Medicina Molecular João Lobo Antunes, Laboratório de Microbiologia, Instituto Gulbenkian de Ciência
ORCID: 0000-0002-2130-3807
Observed ORCID: 0000-0002-2130-3807
OpenAlex ID: A5055278348
Quality and Safety Requirements for Sustainable Phage Therapy Products
2015 · Jean-Paul Pirnay, Bob G. Blasdel, et al. · Pharmaceutical Research · 291
PDF
Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds
2013 · João J. Mendes, Clara Leandro, et al. · Wound Repair and Regeneration · 123
Recombinant Antibodies as Therapeutic Agents: Pathways for Modeling New Biodrugs
2008 · Frederico Aires da Silva, Sofia Corte-Real, et al. · BioDrugs · 68
Antibody Approaches To Treat Brain Diseases
2015 · Vera Neves, Frederico Aires-da-Silva, et al. · Trends in biotechnology · 63
Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcers
2024 · Ran Nir-Paz, Hadil Onallah, et al. · Med · 43
Intrabodies targeting the Kaposi sarcoma–associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells
2005 · Sofia Corte-Real, Chris Collins, et al. · Blood · 41
Cell Type–Specific Targeting with Sindbis Pseudotyped Lentiviral Vectors Displaying Anti-CCR5 Single-Chain Antibodies
2005 · Frederico Aires Da Silva, Maria João Leite Costa, et al. · Human Gene Therapy · 38
A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals
2019 · Diana Chapela, Sara Sousa, et al. · Scientific Reports · 31
PDF
1690. Assessing the safety of TP-102 bacteriophage treatment in the management of diabetic foot infections
2022 · Ran Nir-Paz, Hadil Onallah, et al. · Open Forum Infectious Diseases · 8
Synthetic antibody discovery against native antigens by CRISPR/Cas9-library generation and endoplasmic reticulum screening
2020 · Joana H. Ministro, Soraia S. Oliveira, et al. · Applied Microbiology and Biotechnology · 5
Toxicological evaluation of Alpinia oxyphylla-derived molecule (PD-00105): In vitro genotoxicity studies and 90-day oral toxicity study in rats
2024 · Jérôme Le Bloch, Daniela Jones-Dias, et al. · Toxicology Reports · 3
Intrabody-based Mapping of Latency-associated Nuclear Antigen from Kaposi's Sarcoma-associated Herpesvirus Show Conserved Epitopes for Viral Latency Inhibition
2010 · Sofia Corte-Real, Lídia Fonseca, et al. · Virology Research and Treatment · 1
PDF
KSHV Latency in Transformed B-cells: The Role of LANA1 as a Therapeutic Target
2008 · Sofia Corte-Real, Lídia Fonseca, et al. · Virology Research and Treatment · 1
PDF
Author Correction: A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals
2020 · Diana Chapela, Sara Sousa, et al. · Scientific Reports
PDF
Development of Antibody Fragments for Therapeutic Applications
2011 · Sofia Côrte‐Real, Frederico Aires da Silva, et al. · Wiley eBooks
latency antigen inhibit viral persistence in lymphoma cells Intrabodies targeting the Kaposi sarcoma-associated herpesvirus
2008 · Patrick S. Moore, João Gonçalves, et al.
Works count: 16
Citation count: 716
H-index: 8
I10-index: 8
Year
Topic
Type